Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage
Authors:
- The GEKID Cancer Survival Working GroupTGThe GEKID Cancer Survival Working Group
- Tianhui ChenTCTianhui Chen
- Lina JansenLJLina Jansen
- Adam GondosAGAdam Gondos
- Meike RessingMRMeike Ressing
- Bernd HolleczekBHBernd Holleczek
- Alexander KatalinicAKAlexander Katalinic
- Hermann BrennerHBHermann Brenner
Open Access
- 30 March 2012
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 1-9
Abstract
Population-based studies on endometrial cancer providing survival estimates by age, histology, and stage have been sparse. We aimed to derive most up-to-date and detailed survival estimates for endometrial cancer patients in Germany. We used a pooled German national dataset including data from 11 cancer registries covering a population of 33 million people. 30,906 patients diagnosed with endometrial cancer in 1997-2006 were included. Period analysis was performed to calculate 5-year relative survival (RS) in 2002-2006. Trends in survival between 2002 and 2006 were examined using model-based period analysis. Age-adjustment was performed using five age groups (15-44, 45-54, 55-64, 65-74, and 75+ years). Overall, age-adjusted 5-year relative survival in 2002-2006 was 81%. A moderate age gradient was observed, with 5-year RS decreasing from 90% in the age group 15-49 years to 75% in the age group 70+ years. Furthermore prognosis varied strongly by histologic subtypes and stage, with age-adjusted 5-year RS ranging from 43% (for sarcoma) to 94% (for squamous metaplasia), and reaching 91% for localized, 51% for regional, and 20% for distant stage. Except for age group 65-74 years, no significant improvement in survival was seen during the recent 5-year period under investigation. In this comprehensive population-based survival analysis of patients with endometrial cancer from Germany, prognosis of endometrial cancer moderately varied by age, and strongly varied by histology and stage. While prognosis is rather good overall, further improvement in 5-year relative survival of endometrial cancer patients has been stagnating in the early 21st century.Keywords
This publication has 56 references indexed in Scilit:
- On Estimation in Relative SurvivalBiometrics, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentaryEuropean Journal of Cancer, 2009
- Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)Endocrine-Related Cancer, 2008
- Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 dataThe Lancet Oncology, 2007
- Recent Major Progress in Long-Term Cancer Patient Survival Disclosed by Modeled Period AnalysisJournal of Clinical Oncology, 2007
- Standard cancer patient population for age standardising survival ratiosEuropean Journal of Cancer, 2004
- Period analysis for ‘up-to-date’ cancer survival dataEuropean Journal of Cancer, 2004
- Survival of European women with gynaecological tumours, during the period 1978–1989European Journal of Cancer, 1998
- Uterine sarcomas in Norway 1956–1992: Incidence, survival and mortalityEuropean Journal of Cancer, 1997